EMFAT
AIMT
Emerald Mutual Fund Advisers Trust’s Aimmune Therapeutics, Inc. AIMT Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q3 | – | Sell |
-491,790
| Closed | -$8.22M | – | 376 |
|
|
2020
Q2 | $8.22M | Buy |
491,790
+13,447
| +3% | +$225K | 0.39% | 93 |
|
|
2020
Q1 | $6.9M | Sell |
478,343
-109,121
| -19% | -$1.57M | 0.43% | 83 |
|
|
2019
Q4 | $19.7M | Hold |
587,464
| – | – | 0.8% | 43 |
|
|
2019
Q3 | $12.3M | Sell |
587,464
-189,479
| -24% | -$3.97M | 0.54% | 66 |
|
|
2019
Q2 | $16.2M | Hold |
776,943
| – | – | 0.64% | 53 |
|
|
2019
Q1 | $17.4M | Buy |
776,943
+128,014
| +20% | +$2.86M | 0.7% | 50 |
|
|
2018
Q4 | $15.5M | Buy |
648,929
+187,380
| +41% | +$4.48M | 0.73% | 47 |
|
|
2018
Q3 | $12.6M | Buy |
461,549
+64,467
| +16% | +$1.76M | 0.43% | 93 |
|
|
2018
Q2 | $10.7M | Sell |
397,082
-749
| -0.2% | -$20.1K | 0.39% | 102 |
|
|
2018
Q1 | $12.7M | Buy |
397,831
+749
| +0.2% | +$23.8K | 0.5% | 72 |
|
|
2017
Q4 | $15M | Sell |
397,082
-54,578
| -12% | -$2.06M | 0.6% | 58 |
|
|
2017
Q3 | $11.2M | Sell |
451,660
-7,500
| -2% | -$186K | 0.47% | 78 |
|
|
2017
Q2 | $9.44M | Hold |
459,160
| – | – | 0.41% | 88 |
|
|
2017
Q1 | $9.98M | Sell |
459,160
-148,096
| -24% | -$3.22M | 0.46% | 76 |
|
|
2016
Q4 | $12.4M | Buy |
607,256
+189,042
| +45% | +$3.87M | 0.59% | 62 |
|
|
2016
Q3 | $6.27M | Buy |
418,214
+85,589
| +26% | +$1.28M | 0.32% | 115 |
|
|
2016
Q2 | $3.6M | Buy |
332,625
+3,970
| +1% | +$43K | 0.2% | 139 |
|
|
2016
Q1 | $4.46M | Buy |
328,655
+46,300
| +16% | +$628K | 0.25% | 122 |
|
|
2015
Q4 | $5.21M | Buy |
282,355
+242,075
| +601% | +$4.47M | 0.28% | 115 |
|
|
2015
Q3 | $1.02M | Buy |
+40,280
| New | +$1.02M | 0.07% | 184 |
|